Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Gomisin A inhibits hypoxia/reoxygenation-induced myocardial cell injury by modulating TLR4â€“NF-κB pathway

Tianbao Chen¹, Chengbo Chen¹, Xiaojun Ji², Yuanfang Zhu²

¹Department of Cardiology, Quanzhou First Affiliated Hospital of Fujian Medical University, Quanzhou City, Fujian Province 362000, China; ²Department of Cardiovascular, Wenzhou Central Hospital, Wenzhou City, Zhejiang Province 325000, China.

For correspondence:- Yuanfang Zhu Email: yf_zhu11@163.com Tel:+8657788053151

Accepted: 26 February 2023 Published: 31 March 2023

Citation: Chen T, Chen C, Ji X, Zhu Y. Gomisin A inhibits hypoxia/reoxygenation-induced myocardial cell injury by modulating TLR4â€“NF-κB pathway. Trop J Pharm Res 2023; 22(3):477-483 doi: 10.4314/tjpr.v22i3.3

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To determine the impact of Gomisin A (GomA) on myocardial cell damage caused by hypoxia/reoxygenation (H/R).

Methods: Various methods, including MTT, western blot and flow cytometry were used to to assess the viability of H9c2 cardiomyocytes and cell apoptosis. expression levels of various enzymes and cytokines, including superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β and IL-6 were measured by enzyme-linked immunosorbent assay (ELISA). Western blot was used to evaluate the expression levels of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and Toll-like receptor 4 (TLR4), as well as the phosphorylation of p65 and nuclear factor kappa B (NF-κB) inhibitor alpha (IκBα).

Results: Low concentrations of GomA had no toxic effect on H9c2 cells. In H/R-stressed H9c2 cells, GomA increased cell viability and reduced cell apoptosis, suggesting that GomA inhibited H/R-induced cell apoptosis. Additionally, GomA alleviated H/R-induced oxidative stress and inflammation by increasing the expression of SOD and CAT, while decreasing the expression of MDA, iNOS, COX-2, TNF-α, IL-1β, and IL-6. GomA also suppressed the H/R-induced TLR4–NF-κB pathway by reducing the expression of TLR4 and the phosphorylation of p65 and IκBα.

Conclusion: These results indicate that GomA is a potential candidate for the treatment of myocardial ischemia/reperfusion (MI/R) injury by increasing cell viability, reducing cell apoptosis, alleviating oxidative stress, and reducing inflammation by inhibiting TLR4–NF-κB pathway.

Keywords: Cell injury, Gomisin A, Myocardial cells, NF-Îšb, TLR4, Inflammatory cytokines, Hypoxia-reperfusion